Proposed Data Collection Submitted for Public Comment and Recommendations, 56827-56830 [2023-17924]

Download as PDF 56827 Federal Register / Vol. 88, No. 160 / Monday, August 21, 2023 / Notices benchmarking to national data); private research and action organizations focused on men’s and women’s health, child well-being, and marriage and the family; academic researchers in the social and public health sciences; journalists, and many others. This submission requests approval for a revision to NSFG data collection for three years. The revision request includes the increase of the main survey incentive from $40 to $60, a small set of questionnaire revisions beginning in Year 3 (2024) data collection and to conduct several methodological studies designed to improve the efficiency and validity of NSFG data collection for the purposes described above. The total estimated annualized time burden to respondents is 6,584 hours. There is no cost to respondents other than their time. ESTIMATED ANNUALIZED BURDEN HOURS Respondents Household Household Household Household Household member ......................................... Female 15–49 years of age ......... Male 15–49 years of age ............. member ......................................... Individual 15–49 years of age ...... Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Public Health Ethics and Regulations, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2023–17920 Filed 8–18–23; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–23–0666; Docket No. CDC–2023– 0068] Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). AGENCY: ACTION: Notice with comment period. The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled National Healthcare Safety Network (NHSN). NHSN provides facilities, States, regions, and the nation with data necessary to identify problem areas, measure the progress of prevention efforts, and ultimately eliminate healthcare-associated infections (HAIs) nationwide. ddrumheller on DSK120RN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 18:17 Aug 18, 2023 Number of responses Form Jkt 259001 Screener Interview ......................................... Female Interview ............................................ Male Interview ................................................ Screener Verification ...................................... Main Verification ............................................. CDC must receive written comments on or before October 20, 2023. DATES: You may submit comments, identified by Docket No. CDC–2023– 0068 by either of the following methods: • Federal eRulemaking Portal: ww.regulations.gov. Follow the instructions for submitting comments. • Mail: Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H21–8, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. CDC will post, without change, all relevant comments to www.regulations.gov. Please note: Submit all comments through the Federal eRulemaking portal (www.regulations.gov) or by U.S. mail to the address listed above. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H21–8, Atlanta, Georgia 30329; Telephone: 404–639–7570; Email: omb@ cdc.gov. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed ADDRESSES: PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 Average burden/ response (in hours) Responses per respondent 15,000 2,750 2,250 230 150 1 1 1 1 1 5/60 75/60 50/60 2/60 5/60 extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. The OMB is particularly interested in comments that will help: 1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; 2. Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; 3. Enhance the quality, utility, and clarity of the information to be collected; 4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses; and 5. Assess information collection costs. Proposed Project National Healthcare Safety Network (NHSN) (OMB Control No. 0920–0666, Exp. 6/30/2026)—Revision—National Center for Emerging and Zoonotic Infection Diseases (NCEZID), Centers for Disease Control and Prevention (CDC). Background and Brief Description The Division of Healthcare Quality Promotion (DHQP), National Center for Emerging and Zoonotic Infectious E:\FR\FM\21AUN1.SGM 21AUN1 ddrumheller on DSK120RN23PROD with NOTICES1 56828 Federal Register / Vol. 88, No. 160 / Monday, August 21, 2023 / Notices Diseases (NCEZID), Centers for Disease Control and Prevention (CDC) collects data from healthcare facilities in the National Healthcare Safety Network (NHSN) (OMB Control No. 0920–0666). NHSN provides facilities, States, regions, and the nation with data necessary to identify problem areas, measure the progress of prevention efforts, and ultimately eliminate healthcare-associated infections (HAIs) nationwide. NHSN allows healthcare facilities to track blood safety errors and various healthcare-associated infection prevention practice methods such as healthcare personnel influenza vaccine status and corresponding infection control adherence rates. NHSN currently has seven components: Patient Safety (PS), Healthcare Personnel Safety (HPS), Biovigilance (BV), Long-Term Care Facility (LTCF), Outpatient Procedure (OPC), Dialysis, and Neonatal Component. Data reported under the PS Component are used to determine the magnitude of the healthcare-associated adverse events and trends in the rates of the events, in the distribution of pathogens, and in the adherence to prevention practices. Data will help detect changes in the epidemiology of adverse events resulting from new medical therapies and changing patient risks. Additionally, reported data is being used to describe the epidemiology of antimicrobial use and resistance and to better understand the relationship of antimicrobial therapy to this rising problem. Under the HPS Component, protocols and data on events—both positive and adverse—are used to determine: (1) the magnitude of adverse events in healthcare personnel; and (2) compliance with immunization and sharps injuries safety guidelines. Under the BV Component, data on adverse reactions and incidents associated with blood transfusions are reported and analyzed to provide national estimates of adverse reactions and incidents. Under the LTCF Component, data is captured from skilled nursing facilities. Reporting methods under the LTCF component have been created by using forms from the PS Component as a model with modifications to specifically address the specific characteristics of LTCF residents and the unique data needs of these facilities reporting into NHSN. The Respiratory Tract Infection Form (RTI)—will not to be used by NHSN users, but as part of an EIP project with four EIP sites. The Form is VerDate Sep<11>2014 18:17 Aug 18, 2023 Jkt 259001 titled Denominators for Healthcare Associated Infections (HAIs): Respiratory Tract Infections. The purpose of this form is to allow testing prior to introducing a new module and forms to NHSN users. The CDC’s Epidemiology Research & Innovations Branch (ERIB) team will use the form to perform field testing of variables to explore the utilization, applicability, and data collection burden associated with these variables. This process will inform areas of improvement prior to incorporating the new module, including protocol, forms, and instructions into NHSN. The Dialysis Component offers a simplified user interface for dialysis users to streamline their data entry and analysis processes as well as provide options for expanding in the future to include dialysis surveillance in settings other than outpatient facilities. The Outpatient Procedure Component (OPC) gathers data on the impact of infections and outcomes related to operative procedures performed in Ambulatory Surgery Centers (ASCs). The OPC is used to monitor two event types: Same Day Outcome Measures and Surgical Site Infections (SSIs). The Neonatal Component focuses on premature neonates and the healthcare associated events that occur as a result of their prematurity. This component currently has one module, which includes Late Onset-Sepsis and Meningitis. NHSN has increasingly served as the operating system for HAI reporting compliance through legislation established by the States. As of July 2023, 37 States, the District of Columbia and the City of Philadelphia, Pennsylvania have opted to use NHSN as their primary system for mandated reporting. Reporting compliance is completed by healthcare facilities in their respective jurisdictions, with emphasis on those States and municipalities acquiring varying consequences for failure to use NHSN. Additionally, healthcare facilities in five U.S. territories (Puerto Rico, American Samoa, the U.S. Virgin Islands, Guam, and the Northern Mariana Islands) are voluntarily reporting to NHSN. Additional territories are projected to follow with similar use of NHSN for reporting purposes. NHSN’s data is used to aid in the tracking of HAIs and guide infection prevention activities/practices that protect patients. The Centers for Medicare and Medicaid Services (CMS) and other payers use these data to PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 determine incentives for performance at healthcare facilities across the U.S. and surrounding territories, and members of the public may use some protected data to inform their selection among available providers. Each of these parties is dependent on the completeness and accuracy of the data. CDC and CMS work closely and are fully committed to ensuring complete and accurate reporting, which are critical for protecting patients and guiding national, State, and local prevention priorities. CMS collects some HAI data and healthcare personnel influenza vaccination summary data, which is done on a voluntary basis as part of its Fee-for-Service Medicare quality reporting programs, while others may report data required by a Federal mandate. Facilities that fail to report quality measure data are subject to partial payment reduction in the applicable Medicare Fee-for-Service payment system. CMS links their quality reporting to payment for Medicare-eligible acute care hospitals, inpatient rehabilitation facilities, longterm acute care facilities, oncology hospitals, inpatient psychiatric facilities, dialysis facilities, and ambulatory surgery centers. Facilities report HAI data and healthcare personnel influenza vaccination summary data to CMS via NHSN as part of CMS’s quality reporting programs to receive full payment. Still, many healthcare facilities, even in States without HAI reporting legislation, submit limited HAI data to NHSN voluntarily. NHSN’s data collection updates continue to support the incentive programs managed by CMS. For example, survey questions support requirements for CMS’ quality reporting programs. Additionally, CDC has collaborated with CMS on a voluntary National Nursing Home Quality Collaborative, which focuses on recruiting nursing homes to report HAI data to NHSN and to retain their continued participation. The NHSN data collection was previously approved in June of 2023 for 6,209,922 responses and 1,693,215 annual burden hours. The proposed changes in this Revision include modifications to 15 existing data collection forms and one new form. CDC requests OMB approval for an estimated annual burden 1,524,039 hours. There is no cost to respondents other than their time to participate. E:\FR\FM\21AUN1.SGM 21AUN1 56829 Federal Register / Vol. 88, No. 160 / Monday, August 21, 2023 / Notices ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents ddrumheller on DSK120RN23PROD with NOTICES1 Form number & name 57.100 NHSN Registration Form ..................................................................... 57.101 Facility Contact Information ................................................................. 57.103 Patient Safety Component—Annual Hospital Survey ......................... 57.104 Facility Administrator Change Request Form ..................................... 57.105 Group Contact Information .................................................................. 57.106 Patient Safety Monthly Reporting Plan ............................................... 57.108 Primary Bloodstream Infection (BSI) ................................................... 57.111 Pneumonia (PNEU) ............................................................................. 57.112 Ventilator-Associated Event ................................................................ 57.113 Pediatric Ventilator-Associated Event (PedVAE) ................................ 57.114 Urinary Tract Infection (UTI) ................................................................ 57.115 Custom Event ...................................................................................... 57.116 Denominators for Neonatal Intensive Care Unit (NICU) ..................... 57.117 Denominators for Specialty Care Area (SCA)/Oncology (ONC) ......... 57.118 Denominators for Intensive Care Unit (ICU)/Other locations (not NICU or SCA) .............................................................................................. 57.120 Surgical Site Infection (SSI) ................................................................ 57.121 Denominator for Procedure ................................................................. 57.122 HAI Progress Report State Health Department Survey ...................... 57.123 Antimicrobial Use and Resistance (AUR)-Microbiology Data Electronic Upload Specification Tables .............................................................. 57.124 Antimicrobial Use and Resistance (AUR)-Pharmacy Data Electronic Upload Specification Tables ........................................................................ 57.125 Central Line Insertion Practices Adherence Monitoring ...................... 57.126 MDRO or CDI Infection Form .............................................................. 57.127 MDRO and CDI Prevention Process and Outcome Measures Monthly Monitoring ................................................................................................. 57.128 Laboratory-identified MDRO or CDI Event .......................................... 57.129 Adult Sepsis ......................................................................................... 57.135 Late Onset Sepsis/Meningitis Denominator Form: Data Table for monthly electronic upload ............................................................................ 57.136 Late Onset Sepsis/Meningitis Event Form: Data Table for Monthly Electronic Upload ......................................................................................... 57.137 Long-Term Care Facility Component—Annual Facility Survey ........... 57.138 Laboratory-identified MDRO or CDI Event for LTCF .......................... 57.139 MDRO and CDI Prevention Process Measures Monthly Monitoring for LTCF ....................................................................................................... 57.140 Urinary Tract Infection (UTI) for LTCF ................................................ 57.141 Monthly Reporting Plan for LTCF ........................................................ 57.142 Denominators for LTCF Locations ...................................................... 57.143 Prevention Process Measures Monthly Monitoring for LTCF ............. 57.150 LTAC Annual Survey ........................................................................... 57.151 Rehab Annual Survey ......................................................................... 57.200 Healthcare Personnel Safety Component Annual Facility Survey ...... 57.204 Healthcare Worker Demographic Data ............................................... 57.205 Exposure to Blood/Body Fluids ........................................................... 57.206 Healthcare Worker Prophylaxis/Treatment .......................................... 57.207 Follow-Up Laboratory Testing ............................................................. 57.210 Healthcare Worker Prophylaxis/Treatment-Influenza .......................... 57.300 Hemovigilance Module Annual Survey ................................................ 57.301 Hemovigilance Module Monthly Reporting Plan ................................. 57.303 Hemovigilance Module Monthly Reporting Denominators .................. 57.305 Hemovigilance Incident ....................................................................... 57.306 Hemovigilance Module Annual Survey—Non-acute care facility ........ 57.307 Hemovigilance Adverse Reaction—Acute Hemolytic Transfusion Reaction ............................................................................................................ 57.308 Hemovigilance Adverse Reaction—Allergic Transfusion Reaction ..... 57.309 Hemovigilance Adverse Reaction—Delayed Hemolytic Transfusion Reaction ....................................................................................................... 57.310 Hemovigilance Adverse Reaction—Delayed Serologic Transfusion Reaction ....................................................................................................... 57.311 Hemovigilance Adverse Reaction—Febrile Non-hemolytic Transfusion Reaction ............................................................................................ 57.312 Hemovigilance Adverse Reaction—Hypotensive Transfusion Reaction ................................................................................................................ 57.313 Hemovigilance Adverse Reaction—Infection ...................................... 57.314 Hemovigilance Adverse Reaction—Post Transfusion Purpura ........... 57.315 Hemovigilance Adverse Reaction—Transfusion Associated Dyspnea 57.316 Hemovigilance Adverse Reaction—Transfusion Associated Graft vs. Host Disease ................................................................................................ VerDate Sep<11>2014 18:17 Aug 18, 2023 Jkt 259001 PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 Number of responses per respondent Average burden per response (min./hour) Total burden (hours) 2,000 2,000 5,311 800 1,000 6,387 5,775 1,800 5,463 334 6,000 600 1,100 500 1 1 1 1 1 12 5 2 8 1 5 91 12 12 5/60 10/60 135/60 5/60 5/60 15/60 38/60 30/60 28/60 30/60 20/60 35/60 4/60 5/60 167 333 11,950 67 83 19,161 18,288 1800 20,395 167 10,000 31,850 880 500 5,500 6,000 6,000 55 60 9 602 1 5/60 35/60 10/60 28/60 27,500 31,500 602,000 26 5,500 12 5/60 5,500 5,500 500 720 12 213 11 5/60 25/60 30/60 5,500 44,375 3,960 5,500 4,800 50 29 79 250 15/60 20/60 25/60 39,875 126,400 5,208 300 6 5/60 150 300 17,700 1,086 6 1 24 5/60 122/60 20/60 150 35,990 8,688 1,019 339 1,099 714 357 392 1,160 50 50 50 50 50 50 500 500 500 500 500 12 36 12 12 12 1 1 1 200 50 30 50 50 1 12 12 10 1 20/60 35/60 15/60 35/60 5/60 89/60 89/60 480/60 20/60 60/60 15/60 15/60 10/60 85/60 60/60 70/60 10/60 35/60 4,076 7,119 3,297 4,998 357 581 1,721 400 3,333 2,500 375 625 417 708 6,000 7,000 833 292 500 500 4 4 20/60 20/60 667 667 500 1 20/60 167 500 2 20/60 333 500 4 20/60 667 500 500 500 500 1 1 1 1 20/60 20/60 20/60 20/60 167 167 167 167 500 1 20/60 167 E:\FR\FM\21AUN1.SGM 21AUN1 56830 Federal Register / Vol. 88, No. 160 / Monday, August 21, 2023 / Notices ESTIMATED ANNUALIZED BURDEN HOURS—Continued Number of respondents Form number & name 57.317 Hemovigilance Adverse Reaction—Transfusion Related Acute Lung Injury ............................................................................................................. 57.318 Hemovigilance Adverse Reaction—Transfusion Associated Circulatory Overload ......................................................................................... 57.319 Hemovigilance Adverse Reaction—Unknown Transfusion Reaction .. 57.320 Hemovigilance Adverse Reaction—Other Transfusion Reaction ........ 57.400 Outpatient Procedure Component—Annual Facility Survey ............... 57.401 Outpatient Procedure Component—Monthly Reporting Plan ............. 57.402 Outpatient Procedure Component Same Day Outcome Measures .... 57.403 Outpatient Procedure Component—Monthly Denominators for Same Day Outcome Measures .............................................................................. 57.404 Outpatient Procedure Component—SSI Denominator ........................ 57.405 Outpatient Procedure Component—Surgical Site (SSI) Event ........... 57.500 Outpatient Dialysis Center Practices Survey ...................................... 57.501 Dialysis Monthly Reporting Plan .......................................................... 57.502 Dialysis Event ...................................................................................... 57.503 Denominator for Outpatient Dialysis .................................................... 57.504 Prevention Process Measures Monthly Monitoring for Dialysis .......... 57.505 Dialysis Patient Influenza Vaccination ................................................. 57.506 Dialysis Patient Influenza Vaccination Denominator ........................... 57.507 Home Dialysis Center Practices Survey ............................................. Weekly Healthcare Personnel Influenza Vaccination Cumulative Summary for Non-Long-Term Care Facilities ............................................................... Weekly Healthcare Personnel Influenza Vaccination Cumulative Summary for Long-Term Care Facilities ...................................................................... Weekly Resident Influenza Vaccination Cumulative Summary for Long-Term Care Facilities .............................................................................................. Annual Healthcare Personnel Influenza Vaccination Summary ...................... Healthcare-facility onset, antibiotic-treated Clostridioides difficile (C. difficile) Infection (HT–CDI) Event Module Annual Reporting Plan .......................... Total Estimated Annual Burden Hours ..................................................... Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Public Health Ethics and Regulations, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2023–17924 Filed 8–18–23; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Solicitation of Nominations for Appointment to the Board of Scientific Counselors, National Center for Health Statistics Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. ddrumheller on DSK120RN23PROD with NOTICES1 AGENCY: The Centers for Disease Control and Prevention (CDC), within the Department of Health and Human Services (HHS), is seeking nominations for membership on the Board of Scientific Counselors, National Center for Health Statistics (BSC, NCHS). The SUMMARY: VerDate Sep<11>2014 18:17 Aug 18, 2023 Jkt 259001 Frm 00039 Fmt 4703 Average burden per response (min./hour) Total burden (hours) 500 1 20/60 167 500 500 500 350 350 50 2 1 1 1 12 1 20/60 20/60 20/60 10/60 15/60 40/60 333 167 167 117 1,050 33 50 300 300 7,400 7,400 7,400 7,400 1,730 615 615 450 400 100 36 1 12 30 24 12 50 5 1 40/60 10/60 35/60 125/60 5/60 27/60 10/60 75/60 10/60 10/60 36/60 13,333 5,000 6,300 15,417 7,400 99,900 29,600 25,950 5,125 3075 270 125 52 60/60 6,500 1,200 52 60/60 62,400 2,500 5,000 52 1 60/60 120/60 130,000 10,000 7,821 1 10/60 1,304 ........................ ........................ ........................ 1,524,039 BSC, NCHS consists of up to 15 experts including the Chair in fields associated with the scientific and technical program objectives of the Center. DATES: Nominations for membership on the BSC, NCHS will be accepted on a rolling basis. To be considered for the upcoming nomination slate, submissions should be received no later than September 22, 2023. Submissions received after this time will not be considered for the current membership cycle. ADDRESSES: All nominations should be emailed to NCHS-BSCmail@cdc.gov. FOR FURTHER INFORMATION CONTACT: Rebecca Hines, M.H.S., Designated Federal Officer, Board of Scientific Counselors, National Center for Health Statistics, Centers for Disease Control and Prevention, 3311 Toledo Road, Mailstop P–08, Hyattsville, Maryland 20782. Telephone: (301) 458–4715; Email: RSHines@cdc.gov. SUPPLEMENTARY INFORMATION: Nominations are sought for individuals who have the expertise and qualifications necessary to contribute to the accomplishment of the objective of the Board of Scientific Counselors, PO 00000 Number of responses per respondent Sfmt 4703 National Center for Health Statistics (BSC, NCHS) to provide advice and guidance on statistical and epidemiological research, data collection, and activities that support NCHS, such as: determinants of health; extent and nature of illness and disability, including life expectancy; incidence of various acute and chronic illnesses/impairments and accidental injuries; prevalence of chronic diseases and impairments; infant and maternal morbidity and mortality; nutrition status; environmental, social, and other hazards affecting health status; health resources associated with physician and dental visits, hospitalizations, nursing, extended care facilities, home health agencies, and other health institutions; utilization of health care in a broad array of settings; trends in prices/costs and sources of payments; federal, state, and local government expenditures for health care services; the relationship between demographic and socioeconomic characteristics and health characteristics; family formation, growth, and dissolution; new or improved methods for obtaining current data on the aforementioned factors; data security and confidentiality and E:\FR\FM\21AUN1.SGM 21AUN1

Agencies

[Federal Register Volume 88, Number 160 (Monday, August 21, 2023)]
[Notices]
[Pages 56827-56830]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-17924]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-23-0666; Docket No. CDC-2023-0068]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a continuing information 
collection, as required by the Paperwork Reduction Act of 1995. This 
notice invites comment on a proposed information collection project 
titled National Healthcare Safety Network (NHSN). NHSN provides 
facilities, States, regions, and the nation with data necessary to 
identify problem areas, measure the progress of prevention efforts, and 
ultimately eliminate healthcare-associated infections (HAIs) 
nationwide.

DATES: CDC must receive written comments on or before October 20, 2023.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2023-
0068 by either of the following methods:
     Federal eRulemaking Portal: ww.regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS H21-8, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to www.regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (www.regulations.gov) or by U.S. mail to the address listed 
above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570; 
Email: [email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses; and
    5. Assess information collection costs.

Proposed Project

    National Healthcare Safety Network (NHSN) (OMB Control No. 0920-
0666, Exp. 6/30/2026)--Revision--National Center for Emerging and 
Zoonotic Infection Diseases (NCEZID), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    The Division of Healthcare Quality Promotion (DHQP), National 
Center for Emerging and Zoonotic Infectious

[[Page 56828]]

Diseases (NCEZID), Centers for Disease Control and Prevention (CDC) 
collects data from healthcare facilities in the National Healthcare 
Safety Network (NHSN) (OMB Control No. 0920-0666). NHSN provides 
facilities, States, regions, and the nation with data necessary to 
identify problem areas, measure the progress of prevention efforts, and 
ultimately eliminate healthcare-associated infections (HAIs) 
nationwide. NHSN allows healthcare facilities to track blood safety 
errors and various healthcare-associated infection prevention practice 
methods such as healthcare personnel influenza vaccine status and 
corresponding infection control adherence rates. NHSN currently has 
seven components: Patient Safety (PS), Healthcare Personnel Safety 
(HPS), Biovigilance (BV), Long-Term Care Facility (LTCF), Outpatient 
Procedure (OPC), Dialysis, and Neonatal Component.
    Data reported under the PS Component are used to determine the 
magnitude of the healthcare-associated adverse events and trends in the 
rates of the events, in the distribution of pathogens, and in the 
adherence to prevention practices. Data will help detect changes in the 
epidemiology of adverse events resulting from new medical therapies and 
changing patient risks. Additionally, reported data is being used to 
describe the epidemiology of antimicrobial use and resistance and to 
better understand the relationship of antimicrobial therapy to this 
rising problem. Under the HPS Component, protocols and data on events--
both positive and adverse--are used to determine: (1) the magnitude of 
adverse events in healthcare personnel; and (2) compliance with 
immunization and sharps injuries safety guidelines. Under the BV 
Component, data on adverse reactions and incidents associated with 
blood transfusions are reported and analyzed to provide national 
estimates of adverse reactions and incidents. Under the LTCF Component, 
data is captured from skilled nursing facilities. Reporting methods 
under the LTCF component have been created by using forms from the PS 
Component as a model with modifications to specifically address the 
specific characteristics of LTCF residents and the unique data needs of 
these facilities reporting into NHSN. The Respiratory Tract Infection 
Form (RTI)--will not to be used by NHSN users, but as part of an EIP 
project with four EIP sites. The Form is titled Denominators for 
Healthcare Associated Infections (HAIs): Respiratory Tract Infections. 
The purpose of this form is to allow testing prior to introducing a new 
module and forms to NHSN users. The CDC's Epidemiology Research & 
Innovations Branch (ERIB) team will use the form to perform field 
testing of variables to explore the utilization, applicability, and 
data collection burden associated with these variables. This process 
will inform areas of improvement prior to incorporating the new module, 
including protocol, forms, and instructions into NHSN. The Dialysis 
Component offers a simplified user interface for dialysis users to 
streamline their data entry and analysis processes as well as provide 
options for expanding in the future to include dialysis surveillance in 
settings other than outpatient facilities. The Outpatient Procedure 
Component (OPC) gathers data on the impact of infections and outcomes 
related to operative procedures performed in Ambulatory Surgery Centers 
(ASCs). The OPC is used to monitor two event types: Same Day Outcome 
Measures and Surgical Site Infections (SSIs). The Neonatal Component 
focuses on premature neonates and the healthcare associated events that 
occur as a result of their prematurity. This component currently has 
one module, which includes Late Onset-Sepsis and Meningitis. NHSN has 
increasingly served as the operating system for HAI reporting 
compliance through legislation established by the States. As of July 
2023, 37 States, the District of Columbia and the City of Philadelphia, 
Pennsylvania have opted to use NHSN as their primary system for 
mandated reporting. Reporting compliance is completed by healthcare 
facilities in their respective jurisdictions, with emphasis on those 
States and municipalities acquiring varying consequences for failure to 
use NHSN. Additionally, healthcare facilities in five U.S. territories 
(Puerto Rico, American Samoa, the U.S. Virgin Islands, Guam, and the 
Northern Mariana Islands) are voluntarily reporting to NHSN. Additional 
territories are projected to follow with similar use of NHSN for 
reporting purposes. NHSN's data is used to aid in the tracking of HAIs 
and guide infection prevention activities/practices that protect 
patients. The Centers for Medicare and Medicaid Services (CMS) and 
other payers use these data to determine incentives for performance at 
healthcare facilities across the U.S. and surrounding territories, and 
members of the public may use some protected data to inform their 
selection among available providers. Each of these parties is dependent 
on the completeness and accuracy of the data. CDC and CMS work closely 
and are fully committed to ensuring complete and accurate reporting, 
which are critical for protecting patients and guiding national, State, 
and local prevention priorities. CMS collects some HAI data and 
healthcare personnel influenza vaccination summary data, which is done 
on a voluntary basis as part of its Fee-for-Service Medicare quality 
reporting programs, while others may report data required by a Federal 
mandate. Facilities that fail to report quality measure data are 
subject to partial payment reduction in the applicable Medicare Fee-
for-Service payment system. CMS links their quality reporting to 
payment for Medicare-eligible acute care hospitals, inpatient 
rehabilitation facilities, long-term acute care facilities, oncology 
hospitals, inpatient psychiatric facilities, dialysis facilities, and 
ambulatory surgery centers. Facilities report HAI data and healthcare 
personnel influenza vaccination summary data to CMS via NHSN as part of 
CMS's quality reporting programs to receive full payment. Still, many 
healthcare facilities, even in States without HAI reporting 
legislation, submit limited HAI data to NHSN voluntarily. NHSN's data 
collection updates continue to support the incentive programs managed 
by CMS. For example, survey questions support requirements for CMS' 
quality reporting programs. Additionally, CDC has collaborated with CMS 
on a voluntary National Nursing Home Quality Collaborative, which 
focuses on recruiting nursing homes to report HAI data to NHSN and to 
retain their continued participation.
    The NHSN data collection was previously approved in June of 2023 
for 6,209,922 responses and 1,693,215 annual burden hours. The proposed 
changes in this Revision include modifications to 15 existing data 
collection forms and one new form. CDC requests OMB approval for an 
estimated annual burden 1,524,039 hours. There is no cost to 
respondents other than their time to participate.

[[Page 56829]]



                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
               Form number & name                    Number of     responses per   per response    Total burden
                                                    respondents     respondent      (min./hour)       (hours)
----------------------------------------------------------------------------------------------------------------
57.100 NHSN Registration Form...................           2,000               1            5/60             167
57.101 Facility Contact Information.............           2,000               1           10/60             333
57.103 Patient Safety Component--Annual Hospital           5,311               1          135/60          11,950
 Survey.........................................
57.104 Facility Administrator Change Request                 800               1            5/60              67
 Form...........................................
57.105 Group Contact Information................           1,000               1            5/60              83
57.106 Patient Safety Monthly Reporting Plan....           6,387              12           15/60          19,161
57.108 Primary Bloodstream Infection (BSI)......           5,775               5           38/60          18,288
57.111 Pneumonia (PNEU).........................           1,800               2           30/60            1800
57.112 Ventilator-Associated Event..............           5,463               8           28/60          20,395
57.113 Pediatric Ventilator-Associated Event                 334               1           30/60             167
 (PedVAE).......................................
57.114 Urinary Tract Infection (UTI)............           6,000               5           20/60          10,000
57.115 Custom Event.............................             600              91           35/60          31,850
57.116 Denominators for Neonatal Intensive Care            1,100              12            4/60             880
 Unit (NICU)....................................
57.117 Denominators for Specialty Care Area                  500              12            5/60             500
 (SCA)/Oncology (ONC)...........................
57.118 Denominators for Intensive Care Unit                5,500              60            5/60          27,500
 (ICU)/Other locations (not NICU or SCA)........
57.120 Surgical Site Infection (SSI)............           6,000               9           35/60          31,500
57.121 Denominator for Procedure................           6,000             602           10/60         602,000
57.122 HAI Progress Report State Health                       55               1           28/60              26
 Department Survey..............................
57.123 Antimicrobial Use and Resistance (AUR)-             5,500              12            5/60           5,500
 Microbiology Data Electronic Upload
 Specification Tables...........................
57.124 Antimicrobial Use and Resistance (AUR)-             5,500              12            5/60           5,500
 Pharmacy Data Electronic Upload Specification
 Tables.........................................
57.125 Central Line Insertion Practices                      500             213           25/60          44,375
 Adherence Monitoring...........................
57.126 MDRO or CDI Infection Form...............             720              11           30/60           3,960
57.127 MDRO and CDI Prevention Process and                 5,500              29           15/60          39,875
 Outcome Measures Monthly Monitoring............
57.128 Laboratory-identified MDRO or CDI Event..           4,800              79           20/60         126,400
57.129 Adult Sepsis.............................              50             250           25/60           5,208
57.135 Late Onset Sepsis/Meningitis Denominator              300               6            5/60             150
 Form: Data Table for monthly electronic upload.
57.136 Late Onset Sepsis/Meningitis Event Form:              300               6            5/60             150
 Data Table for Monthly Electronic Upload.......
57.137 Long-Term Care Facility Component--Annual          17,700               1          122/60          35,990
 Facility Survey................................
57.138 Laboratory-identified MDRO or CDI Event             1,086              24           20/60           8,688
 for LTCF.......................................
57.139 MDRO and CDI Prevention Process Measures            1,019              12           20/60           4,076
 Monthly Monitoring for LTCF....................
57.140 Urinary Tract Infection (UTI) for LTCF...             339              36           35/60           7,119
57.141 Monthly Reporting Plan for LTCF..........           1,099              12           15/60           3,297
57.142 Denominators for LTCF Locations..........             714              12           35/60           4,998
57.143 Prevention Process Measures Monthly                   357              12            5/60             357
 Monitoring for LTCF............................
57.150 LTAC Annual Survey.......................             392               1           89/60             581
57.151 Rehab Annual Survey......................           1,160               1           89/60           1,721
57.200 Healthcare Personnel Safety Component                  50               1          480/60             400
 Annual Facility Survey.........................
57.204 Healthcare Worker Demographic Data.......              50             200           20/60           3,333
57.205 Exposure to Blood/Body Fluids............              50              50           60/60           2,500
57.206 Healthcare Worker Prophylaxis/Treatment..              50              30           15/60             375
57.207 Follow-Up Laboratory Testing.............              50              50           15/60             625
57.210 Healthcare Worker Prophylaxis/Treatment-               50              50           10/60             417
 Influenza......................................
57.300 Hemovigilance Module Annual Survey.......             500               1           85/60             708
57.301 Hemovigilance Module Monthly Reporting                500              12           60/60           6,000
 Plan...........................................
57.303 Hemovigilance Module Monthly Reporting                500              12           70/60           7,000
 Denominators...................................
57.305 Hemovigilance Incident...................             500              10           10/60             833
57.306 Hemovigilance Module Annual Survey--Non-              500               1           35/60             292
 acute care facility............................
57.307 Hemovigilance Adverse Reaction--Acute                 500               4           20/60             667
 Hemolytic Transfusion Reaction.................
57.308 Hemovigilance Adverse Reaction--Allergic              500               4           20/60             667
 Transfusion Reaction...........................
57.309 Hemovigilance Adverse Reaction--Delayed               500               1           20/60             167
 Hemolytic Transfusion Reaction.................
57.310 Hemovigilance Adverse Reaction--Delayed               500               2           20/60             333
 Serologic Transfusion Reaction.................
57.311 Hemovigilance Adverse Reaction--Febrile               500               4           20/60             667
 Non-hemolytic Transfusion Reaction.............
57.312 Hemovigilance Adverse Reaction--                      500               1           20/60             167
 Hypotensive Transfusion Reaction...............
57.313 Hemovigilance Adverse Reaction--Infection             500               1           20/60             167
57.314 Hemovigilance Adverse Reaction--Post                  500               1           20/60             167
 Transfusion Purpura............................
57.315 Hemovigilance Adverse Reaction--                      500               1           20/60             167
 Transfusion Associated Dyspnea.................
57.316 Hemovigilance Adverse Reaction--                      500               1           20/60             167
 Transfusion Associated Graft vs. Host Disease..

[[Page 56830]]

 
57.317 Hemovigilance Adverse Reaction--                      500               1           20/60             167
 Transfusion Related Acute Lung Injury..........
57.318 Hemovigilance Adverse Reaction--                      500               2           20/60             333
 Transfusion Associated Circulatory Overload....
57.319 Hemovigilance Adverse Reaction--Unknown               500               1           20/60             167
 Transfusion Reaction...........................
57.320 Hemovigilance Adverse Reaction--Other                 500               1           20/60             167
 Transfusion Reaction...........................
57.400 Outpatient Procedure Component--Annual                350               1           10/60             117
 Facility Survey................................
57.401 Outpatient Procedure Component--Monthly               350              12           15/60           1,050
 Reporting Plan.................................
57.402 Outpatient Procedure Component Same Day                50               1           40/60              33
 Outcome Measures...............................
57.403 Outpatient Procedure Component--Monthly                50             400           40/60          13,333
 Denominators for Same Day Outcome Measures.....
57.404 Outpatient Procedure Component--SSI                   300             100           10/60           5,000
 Denominator....................................
57.405 Outpatient Procedure Component--Surgical              300              36           35/60           6,300
 Site (SSI) Event...............................
57.500 Outpatient Dialysis Center Practices                7,400               1          125/60          15,417
 Survey.........................................
57.501 Dialysis Monthly Reporting Plan..........           7,400              12            5/60           7,400
57.502 Dialysis Event...........................           7,400              30           27/60          99,900
57.503 Denominator for Outpatient Dialysis......           7,400              24           10/60          29,600
57.504 Prevention Process Measures Monthly                 1,730              12           75/60          25,950
 Monitoring for Dialysis........................
57.505 Dialysis Patient Influenza Vaccination...             615              50           10/60           5,125
57.506 Dialysis Patient Influenza Vaccination                615               5           10/60            3075
 Denominator....................................
57.507 Home Dialysis Center Practices Survey....             450               1           36/60             270
Weekly Healthcare Personnel Influenza                        125              52           60/60           6,500
 Vaccination Cumulative Summary for Non-Long-
 Term Care Facilities...........................
Weekly Healthcare Personnel Influenza                      1,200              52           60/60          62,400
 Vaccination Cumulative Summary for Long-Term
 Care Facilities................................
Weekly Resident Influenza Vaccination Cumulative           2,500              52           60/60         130,000
 Summary for Long-Term Care Facilities..........
Annual Healthcare Personnel Influenza                      5,000               1          120/60          10,000
 Vaccination Summary............................
Healthcare-facility onset, antibiotic-treated              7,821               1           10/60           1,304
 Clostridioides difficile (C. difficile)
 Infection (HT-CDI) Event Module Annual
 Reporting Plan.................................
                                                 ---------------------------------------------------------------
    Total Estimated Annual Burden Hours.........  ..............  ..............  ..............       1,524,039
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2023-17924 Filed 8-18-23; 8:45 am]
BILLING CODE 4163-18-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.